Published in J Natl Cancer Inst on December 21, 2011
MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed (2012) 1.05
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. Haematologica (2013) 1.03
Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma. Cancer Manag Res (2015) 0.78
Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma. Mediterr J Hematol Infect Dis (2012) 0.75
Follicular lymphoma: to treat or not to treat is no longer the question. J Natl Cancer Inst (2011) 0.75
Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma. Bone Marrow Res (2012) 0.75
The Expression of CD9 and PIK3CD is Associated with Prognosis of Follicular Lymphoma. J Cancer (2015) 0.75
Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience. Med Oncol (2014) 0.75
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71
GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02
Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20
High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90
Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med (2012) 5.67
Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57
A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med (2015) 5.28
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16
A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ (2002) 4.84
Internet versus mailed questionnaires: a randomized comparison (2). J Med Internet Res (2004) 4.45
The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med (2009) 4.41
Need for expertise based randomised controlled trials. BMJ (2005) 4.34
An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA (2009) 3.81
A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol (2008) 3.75
The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62
Physicians' and patients' choices in evidence based practice. BMJ (2002) 3.57
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ (2010) 3.54
Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev (2011) 3.44
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J Clin Oncol (2009) 3.38
Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg Am (2003) 3.36
Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol (2002) 3.36
Validity of composite end points in clinical trials. BMJ (2005) 3.26
Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22
Internal fixation compared with arthroplasty for displaced fractures of the femoral neck. A meta-analysis. J Bone Joint Surg Am (2003) 3.14
Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ (2010) 3.13
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ (2007) 3.06
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 2.95
Does ratification of human-rights treaties have effects on population health? Lancet (2009) 2.93
Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care (2004) 2.93
Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med (2012) 2.91
Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med (2007) 2.82
Progress in evidence-based medicine. JAMA (2008) 2.77
Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis. CMAJ (2004) 2.76
Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ (2012) 2.69
Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69
A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med (2004) 2.68
Operative management of displaced femoral neck fractures in elderly patients. An international survey. J Bone Joint Surg Am (2005) 2.68
Internet versus mailed questionnaires: a controlled comparison (2). J Med Internet Res (2004) 2.59
Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club (2002) 2.58
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev (2013) 2.58
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Users' guide to detecting misleading claims in clinical research reports. BMJ (2004) 2.55
The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol (2009) 2.55
Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail (2013) 2.50
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
New markers of inflammation and endothelial cell activation: Part I. Circulation (2003) 2.43
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol (2011) 2.40
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. N Engl J Med (2011) 2.32
How to use an article reporting a multiple treatment comparison meta-analysis. JAMA (2012) 2.28
A systematic review of studies comparing health outcomes in Canada and the United States. Open Med (2007) 2.26
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood (2009) 2.22
Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med (2007) 2.21
Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol (2007) 2.20
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia. Blood (2008) 2.18
Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials. BMJ (2009) 2.15
Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med (2012) 2.15
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ (2008) 2.15
Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD (2005) 2.12
Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am (2005) 2.05
Design, analysis, and presentation of crossover trials. Trials (2009) 2.01
Patient-important outcomes in registered diabetes trials. JAMA (2008) 2.00
A practical approach to evidence-based dentistry: IX: how to appraise and use an article about economic analysis. J Am Dent Assoc (2015) 1.99
A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies. Blood (2012) 1.95
Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ (2010) 1.95
Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ (2004) 1.92
Survey of interventions for the prevention and treatment of acute respiratory distress syndrome. Crit Care Med (2004) 1.90
Randomized trials in oncology stopped early for benefit. J Clin Oncol (2008) 1.89
A randomized trial of opinion leader endorsement in a survey of orthopaedic surgeons: effect on primary response rates. Int J Epidemiol (2003) 1.86
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ (2012) 1.85
Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol (2003) 1.83
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. Lancet Oncol (2011) 1.81
Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma (2008) 1.80
Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med (2007) 1.80
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial. Lancet Oncol (2011) 1.75
Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol (2003) 1.75
Iraq War mortality estimates: a systematic review. Confl Health (2008) 1.72
A study of the physiologic responses to a lung recruitment maneuver in acute lung injury and acute respiratory distress syndrome. Respir Care (2008) 1.65
Interpreting the results of patient reported outcome measures in clinical trials: the clinician's perspective. Health Qual Life Outcomes (2006) 1.64
Commentary--goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res (2005) 1.63
Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J Clin Epidemiol (2007) 1.63
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol (2003) 1.63
Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis. J Natl Cancer Inst (2004) 1.59
A lack of consensus in the assessment of fracture healing among orthopaedic surgeons. J Orthop Trauma (2002) 1.56
Current management of tibial shaft fractures: a survey of 450 Canadian orthopedic trauma surgeons. Acta Orthop (2008) 1.55